CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Total liabilities 2016–2025
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) total liabilities at each fiscal year-end, per SEC filings.
$3.9BFY2025 · since FY2016: $1.9B → $3.9B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $3.9B | -2.4% |
| FY2024 | $4.0B | -11.4% |
| FY2023 | $4.5B | -0.9% |
| FY2022 | $4.6B | +3.3% |
| FY2021 | $4.4B | +32.4% |
| FY2020 | $3.3B | +10.6% |
| FY2019 | $3.0B | +20.2% |
| FY2018 | $2.5B | +34.9% |
| FY2017 | $1.9B | +0.4% |
| FY2016 | $1.9B | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice